Clinical Trial Update: Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection [Phase 2]

View source ↗

Summary

An update on a Phase 2 study evaluating VAC-3S in combination with standard antiretroviral therapy for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VAC-3S

Snippet

Sponsor: InnaVirVax | Conditions: HIV | Phase 2 | Status: UNKNOWN